A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation
NCT ID: NCT01209559
Last Updated: 2018-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2011-01-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Intubating Laryngeal Airway in Children
NCT00885911
The Laryngeal Mask Airway (LMA) Unique and the Air-Q Intubating Laryngeal Airway (ILA) in Pediatric Patients
NCT01314248
Air-Q Intubating Laryngeal Airway Versus the Laryngeal Mask Airway (LMA)-Proseal
NCT01328405
Evaluation of the Intubating Laryngeal Airway in Children
NCT01029431
LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children
NCT01385761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
air-Q Intubating Laryngeal Airway
No interventions assigned to this group
LMA FastrachTM or ILMA
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* a BMI ≥ 40kg.m-2,
* require endotracheal intubation,
* have predictors of difficult intubation,
* not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm,
* cannot consent to the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orlando Hung
MD FRCPC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-RS/2011-156
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.